Bioject To Report Third-Quarter 2003 Financial Results.

Business Editors

BEDMINSTER, N.J.--(BUSINESS WIRE)--Oct. 20, 2003

Bioject Medical Technologies Inc., (Nasdaq: BJCT), a leading developer of needle-free drug delivery systems, announced today that the Company will report its financial results for the third quarter ended September 30, 2003 on Monday, October 27, 2003, after the close of the financial markets. Management will conduct a conference call on Tuesday, October 28, 2003, at 10:00 a.m. Eastern Standard Time to review the results for the quarter. Jim O'Shea, Chairman, President, and CEO, and John Gandolfo, Chief Financial Officer, will be hosting the call.

Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to investors, members of the news media and the general public. To participate in the call via telephone, please dial 1-877-407-8037, or to access the call live over the Internet, visit Bioject's website at www.bioject.com and click on the Investor Relations section, then on the event icon. A conference call replay will also be available until November 4, 2003. To listen to the replay, please dial 1-877-660-6853, replay account number 7303, replay conference number 80280.

Bioject Medical Technologies Inc., based in Bedminster, New Jersey, with operations in Portland, Oregon, is an innovative developer and manufacturer of needle-free drug delivery systems. Needle-free injection works by forcing medication at high speed through a tiny orifice held against the skin. This creates a fine stream of high-pressure fluid penetrating the skin and depositing medication in the tissue beneath. The Company is focused on developing mutually beneficial agreements with leading pharmaceutical, biotechnology, and veterinary companies.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Readers of this press release are referred to the Company's filings with the Securities and Exchange Commission, including the Company's reports on Forms 10-K and Forms 10-Q for further discussions of factors that could affect future results. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. The Company assumes no obligation to update forward-looking statements if conditions or management's estimates or opinions should change.

For more information about Bioject, visit: www.bioject.com.